Actilyse Cathflo

Actilyse Cathflo, containing Alteplase, is a pharmaceutical solution for intravenous use, designed to address specific medical conditions. This product is manufactured by Boehringer Ingelheim International Gmbh and is available in the EU market.

Actilyse Cathflo is primarily used for the restoration of catheter patency in patients with central venous access devices. Alteplase, the active ingredient, works by breaking down blood clots, which can help maintain the functionality of the catheter. This medication is often employed when other methods of clearing the catheter have been unsuccessful.

When administered intravenously, Actilyse Cathflo may help dissolve clots that obstruct the catheter. Patients might experience improved catheter function, allowing for the continued administration of necessary treatments. The effects of Alteplase are typically observed within a few hours of administration.

Actilyse Cathflo should be handled with care, ensuring proper storage and administration protocols are followed. Patients with a history of bleeding disorders or recent surgery should consult their healthcare provider before use. Always follow the guidance of a medical professional when using this medication.

Actilyse Cathflo may interact with other medications, particularly those that affect blood clotting. Patients taking anticoagulants or antiplatelet drugs should be cautious and consult their healthcare provider. Additionally, the use of Alteplase with other thrombolytic agents should be avoided to prevent potential adverse effects.